136 related articles for article (PubMed ID: 4728419)
1. Serum cholesterol and triglycerides.
Myant NB
Practitioner; 1973 Aug; 211(262):188-92. PubMed ID: 4728419
[No Abstract] [Full Text] [Related]
2. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
Bergqvist N
Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
[No Abstract] [Full Text] [Related]
3. [Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
Stähelin HB; Hartmann G
Dtsch Med Wochenschr; 1974 Jun; 99(26):1392-4 passim. PubMed ID: 4601124
[No Abstract] [Full Text] [Related]
4. [Arteriosclerosis--nicotinic acid therapy. 2. Alterations in serum lipoproteins. Diagnosis, therapy].
Gustafson A
Lakartidningen; 1971 Apr; 68(15):1744-5 passim. PubMed ID: 5577244
[No Abstract] [Full Text] [Related]
5. [Current trends in the therapy of arteriosclerotic disease].
Toscano S
G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
[No Abstract] [Full Text] [Related]
6. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Gustafson A
Postgrad Med J; 1975; 51(8):66-71. PubMed ID: 768950
[No Abstract] [Full Text] [Related]
7. [Long-term management of various hyperlipidemias using clofibrate].
Studlar M; Pichler O; Kindler K
Wien Med Wochenschr; 1975 Dec; 125(50-52):746-51. PubMed ID: 1229130
[No Abstract] [Full Text] [Related]
8. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
Hanefeld M; Schulze J; Fritz T; Kemmer C
Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340
[No Abstract] [Full Text] [Related]
9. [Influence of a combined treatment using clofibrate and persantin persantinat on increased serum lipid levels].
Hammerl H; Nebosis G; Pichler O; Studlar M
Med Welt; 1973 Mar; 24(12):468-70. PubMed ID: 4700881
[No Abstract] [Full Text] [Related]
10. [Clinical and therapeutic evaluation of a new antilipemic substance].
de Aguiar Magano L
Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646
[TBL] [Abstract][Full Text] [Related]
11. Type IV hyperlipoproteinemia. Clofibrate without dietary therapy.
Zelis R; Amsterdam EA; Spann JF; Mason DT
JAMA; 1972 Oct; 222(3):326-8. PubMed ID: 4566727
[No Abstract] [Full Text] [Related]
12. [Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia].
Huth K; Blumenthal J; Schmahl FW
Med Klin; 1973 Aug; 68(34):1089-97. PubMed ID: 4790868
[No Abstract] [Full Text] [Related]
13. [The effect of a combination treatment with clofibrate on the lipoprotein pattern of endogenous hypertriglyceridemia].
Vogelberg KH; Althoff B; Heggen EM; Thesseling W
Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():832-5. PubMed ID: 196437
[No Abstract] [Full Text] [Related]
14. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
[TBL] [Abstract][Full Text] [Related]
15. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
Oriente P; Motolese M; Cerqua R; Mancini M
Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
[No Abstract] [Full Text] [Related]
16. [Pharmacokinetics of clofibrate in uremic patients treated with dialysis. Effects of dietetic and drug therapy on triglycerides in the blood].
Garini G; Vaona GL; Arisi L; Bignardi L; David S; Gaudiano V; Rossi E; Savazzi GM; Cambi V; Migone L
Minerva Nefrol; 1979; 26(1):55-60. PubMed ID: 471323
[No Abstract] [Full Text] [Related]
17. [Comparative studies on the reduction of lipids using clofibric acid and clofibrate in hyperlipoproteinemias].
Schwartzkopff W; Hoffmann H; Kästner W
Med Welt; 1975 Dec; 26(51):2308-15. PubMed ID: 177837
[No Abstract] [Full Text] [Related]
18. Chlorophenoxyisobutyric acid derivatives and apolipoprotein B metabolism.
Shepherd J; Packard CJ
Monogr Atheroscler; 1985; 13():85-91. PubMed ID: 4088282
[No Abstract] [Full Text] [Related]
19. [Correction of hyperdyslipidemia using polyene-structure substances. Controlled clinical trial].
Pagliano FM
Arch Sci Med (Torino); 1979; 136(2):303-8. PubMed ID: 391176
[TBL] [Abstract][Full Text] [Related]
20. Factorial study of the efficacy of cholestyramine, L-tryptophan and clofibrate in human nephrotic hyperlipidaemia.
Schapel GJ; Edwards KD; Neale FC
Prog Biochem Pharmacol; 1974; 9():82-98. PubMed ID: 4438384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
